The percentage of residual DCIS in patients diagnosed with primary invasive breast cancer treated with neoadjuvant systemic therapy: A nationwide retrospective study

Autor: Ploumen, R.A.W., Keymeulen, K.B.M.I., Kooreman, L.F.S., van Kuijk, S.M.J., Siesling, S., Smidt, M.L., van Nijnatten, T.J.A.
Zdroj: In European Journal of Surgical Oncology January 2022 48(1):60-66
Databáze: ScienceDirect
Externí odkaz: